Fate Therapeutics (FATE) R&D US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D, bln rub | 87.8 | 125.6 | 215.5 | 320.5 | 172.6 | 123.5 | |||
Changes by years, y/y, % | +57% | +43% | +72% | +49% | -46% | +25.2% |
Fate Therapeutics. R&D, bln rub
Fate Therapeutics. R&D, changes, %
Fate Therapeutics. R&D, sum by quarters, bln rub
Fate Therapeutics (FATE) R&D US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
R&D, bln rub | 34.3 | 26.9 | 27.3 | 34.6 | 34.7 | 123.5 | ||
Changes by years, y/y, % | -57% | -69% | -58% | -15% | +1% | |||
Changes by quarters, q/q, % | -16% | -21% | +1% | +27% | +0% |